Clinical Trial Update: Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant chemotherapy with selective radiotherapy for intermediate-risk rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo | Conditions: Rectum Cancer | Phase 2 | Status: COMPLETED